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Abstract
Most patients with rheumatoid arthritis (RA) express HLA-DR4, HLA-DR1 or HLA-DR10.
These alleles share a common amino acid motif in their third hypervariable regions: the
shared epitope. In normals and patients with RA, HLA-DR genes exert a major influence on
the CD4 ab T-cell repertoire, as shown by studies of AV and BV gene usage and BV BJ
gene usage by peripheral blood CD4 ab Tcells. However, the rheumatoid T-cell repertoire is
not entirely under HLA-DR influence, as demonstrated by discrepancies in VB JB gene
usage between identical twins discordant for RA and by contraction of the CD4 ab T-cell
repertoire in RA patients. Shared epitope positive HLA-DR alleles may shape the T-cell
repertoire by presenting self peptides to CD4 Tcells in the thymus. Peptides processed
from HLA-DR molecules and encompassing the shared epitope may also be presented by
HLA-DQ and select CD4 ab Tcells in the thymus. Thus, shared epitope-positive alleles
impose a frame on the T-cell repertoire. This predisposing frame is further modified (by
unknown factors) to obtain the contracted rheumatoid repertoire.
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Introduction
Most patients with RA express particular HLA-DR alleles.
These include HLA-DRB1*0401, *0404, *0405 and *0408
(identified by serology as HLA-DR4), HLA-DRB1*0101 and
*0102 (HLA-DR1), and HLA-DRB1*1001 (HLA-DR10).
These alleles share a common structural motif in the third
hypervariable region of their b1 chains. This motif is called
the shared epitope [1]. Its amino acid sequence, using the
one letter amino acid code, is QKRAA (glutamine, lysine,
arginine, alanine, alanine) on HLA-DRB1*0401, QRRAA on
HLA-DRB1*0404, *0405, *0408, *0101 and *0102, and
RRRAA on HLA-DRB1*1001. The shared epitope is
believed to contribute to the development of rheumatoid
arthritis. However, it is not known how. Two opposite
hypotheses propose either that the shared epitope allows
the presentation of target antigenic peptides to T lympho-
cytes or that the shared epitope helps select the T cell
repertoire. In this review, we will focus on the influence of
shared epitope positive HLA-DR alleles on CD4ab T cell
repertoire selection.
Preliminary: how to study the T cell repertoire ?
It is known that ab T cells use a highly polymorphic ab
surface receptor associated with a signal transducing unit
to recognize antigenic peptides in association with class II
major histocompatibility complex (MHC) molecules. Thus,Arthritis Research    Vol 2 No 3 Roudier
the ab T cell repertoire could be characterized by analyz-
ing ab heterodimers on T cells or identifying recognized
peptide–MHC complexes on antigen presenting cells.
Unfortunately, most studies on the human repertoire have
lacked this kind of accuracy, analyzing either T cell
responses to proteins or peptides, or the expression of a
or b T cell receptor (TCR) genes/chains by CD4 T cells. In
the future, the use of soluble peptide–MHC tetramers
should allow a better view of ab T cells and their targets.
Still, these studies are purely descriptive. There is little
information on the functional efficiency of the T cell reper-
toire, which is whether or not a given repertoire is efficient
at controlling a particular bacteria or virus. This efficiency
of the ab T cell repertoire may also be influenced by
HLA-DR.
HLA-DR influence on the T cell repertoire in
normals and RA patients
The variable regions of TCR a and b chains are encoded
by rearranged variable (V), diversity (D) (only in b chains),
and joining (J) segments, with additional N diversity
sequences [2••]. Whereas identical BV, D or BJ genes can
be used by many different T cell receptor b chains, the
sequence of the VDJ junction that constitutes the third
complementarity determining region is unique to a clone.
HLA haplotypes determine AV and BV gene usage by
peripheral blood T cells
AV and BV gene usage on peripheral blood ab T lympho-
cytes was first analyzed by labeling T cells with mono-
clonal antibodies specific for particular Va or Vb families.
This approach showed that HLA haplotypes exert a major
influence on expression of AV and BV genes by peripheral
blood T cells. In this analysis, HLA-identical siblings and
twins had almost identical percentages of peripheral
blood T cells expressing the analyzed Va and Vb chains
[3]. Similar results were obtained using polymerase chain
reaction technology: BV gene expression was identical in
twins, even if they were discordant for RA [4]. These
analyses contradict earlier work that suggested that the
peripheral T cell repertoire in RA was characterized by
expansion of T cells expressing a particular BV [5].
BJ gene usage by T cells expressing particular BV genes:
BV BJ gene usage
More precise TCR B gene expression analysis can be per-
formed by identifying and quantifying, for each of the 24
BV gene families, the BJ genes to which they rearrange.
This is performed by first amplifying cDNA from T lympho-
cytes with a BV family specific and a BC primer, then
hybridizing the amplified material with a labeled probe
specific for each of the 13 BJ families. This technique
allows one to evaluate the percentage of genes from a
given BV family, which is rearranged to each of the 13 BJ
genes. This analysis confirmed the very strong influence of
HLA-DR on the CD4-positive T cell JB gene repertoire in
the BV3, BV14, BV17, BV8 and BV5 families [6,7].
According to this analysis, the peripheral CD4 T cell reper-
toire from healthy shared epitope positive subjects was
different from that of healthy shared epitope negative sub-
jects. Finally, when identical twins discordant for RA were
studied, their BV BJ repertoires appeared almost identical
[8]. However, statistical analysis demonstrated that they
were slightly different [9]. Similar results were obtained by
Walser-Kuntz  et al when comparing the repertoires of
HLA-DR matched RA patients and controls [7]. Thus,
HLA-DR molecules exert a very strong influence on BV BJ
gene usage and may allow the emergence of a repertoire
that will help development of RA. However, discrete differ-
ences exist between the CD4 T cell repertoires of RA
patients and HLA matched controls. These differences
cannot be attributed to genetic factors.
Individual sequences
A further step in the analysis of the BTCR repertoire was
taken by Wagner et al who studied the representation of
individual, arbitrarily picked TCR b chains in the peripheral
repertoire of RA patients and normals [10••]. This was
achieved by amplifying particular BV BJ combinations in
cDNA prepared from different numbers of T cells and looking
for a particular third complementarity determining region
among the amplified rearranged genes by hybridization with
a third complementarity determining region specific probe.
This analysis suggested that, in healthy individuals, the
median frequency of individual TCR b chains was 1 in 24
million. In RA patients, however, this frequency was 10
times higher, which indicated a ‘contraction’ of the T cell
repertoire, with less diversity and emergence of dominant
clones. These findings were valid for both memory
(CD45RO+) and naive (CD45RO–) CD4 T cells.
Thus, individual sequence analysis suggests that RA
patients have a contracted peripheral ab T cell repertoire
and that this pattern is associated with rheumatoid arthritis
[11]. This contraction is not observed in HLA matched
controls, which indicates that at least part of this process
is independent of HLA-DR.
How could shared epitope positive HLA-DR
molecules select the T cell repertoire?
ab T cells rearrange their TCR genes before undergoing
positive and negative selection in the thymus. In positive
selection, CD4 T cells are selected for affinity for self class II
MHC and self peptides. In negative selection, CD4 T cells
with high affinity for self class II MHC and self peptides are
eliminated. HLA-DR molecules may control the binding of
self peptides in the thymus, thus influencing the positive and
negative selection processes. However, there is little infor-
mation on the identity of the self peptides involved in ab
T cell selection, with exception for self peptides derived
from self MHC molecules. Indeed, MHC molecules arehttp://arthritis-research.com/content/2/3/217
highly polymorphic, hence their processing can generate
highly polymorphic peptides. MHC derived self peptides are
well represented among peptides presented by MHC mole-
cules and may be important in shaping the T cell repertoire
in a MHC specific way. In early studies, development of a
mouse model of autoimmunity was attempted by immuniz-
ing normal mice with peptides derived from the third hyper-
variable region of their Eb chains. To our surprise, it was
observed that this polymorphic part of Eb was strongly toler-
ated [12]. We later made the same observation in normal
humans expressing RA associated HLA-DRB1*0401. In
these subjects, peptides encompassing the shared epitope
in the third hypervariable region of HLA-DRB1*0401 did not
trigger proliferation of peripheral blood T lymphocytes, even
though they were presented by HLA-DQ. This suggested
that peptides from the third hypervariable region of
HLA-DRB1*0401, presented by HLA-DQ, could be
involved in negatively selecting the T cell repertoire
[13•,14•]. The fact that this property was not observed for
peptides from the same area of other HLA-DRB1 alleles is
surprising. It may indicate that HLA-DRB1*0401 has an
original processing, perhaps related to an original intracellu-
lar route [15]. Of interest, the third hypervariable region of
HLA-DRB1*0401 has significant sequence homology with
proteins from many infectious agents, like Epstein–Barr
virus gp110 or Escherichia coli DnaJ [16,17]. In 1995,
Albani et al demonstrated that synovial fluid T cells from
patients with rheumatoid arthritis proliferate to peptides
from DnaJ containing the QKRAA motif, and it was
proposed that the third hypervariable region of
HLA-DRB1*0401 could be involved in positive selection of
the ab T cell repertoire [18]. Thus, peptides derived from
the third hypervariable region of HLA-DRB1*0401 may be
involved both in positive and negative selection of the T cell
repertoire. A direct demonstration of this hypothesis will be
difficult to provide. However, a recent study by Bonnin et al
in the mouse demonstrated that a peptide from the third
hypervariable region of the Ea chain could positively select
T cells specific for a bacterial homologue of this peptide
[19•]. In short, HLA-DR molecules may shape the T cell
repertoire by binding unknown peptides involved in thymic
selection. Whereas the identity of these peptides is not
known, it is likely that HLA-DR4 derived peptides are
involved in this process.
Is an HLA-DR4 shaped repertoire efficient at
controlling pathogens?
HLA-DR genes associated with RA shape the T cell
repertoire, as assessed by analysis of T cell receptors.
Does this influence infection control? Some information
in the field of herpes viruses suggests it does. The repli-
cation of herpes viruses is controlled in part by T cells
specific for the highly conserved family of glycoproteins
B. T cell responses to Epstein–Barr virus gp110 (the
glycoprotein B of Epstein–Barr virus) and human
cytomegalovirus glycoprotein B are lowest in normal
subjects expressing HLA-DR4 [20,21]. This may
provide a clue to the origin of the herpes virus overload
observed in patients with RA.
Conclusion: HLA-DR is not enough to make a
rheumatoid repertoire
HLA-DR molecules exert a tight control over the peripheral
blood  ab T cell repertoire. This control may involve the
intervention of HLA-DR derived peptides in the processes
of positive and/or negative selection in the thymus. Still,
the rheumatoid T cell repertoire is not entirely under
HLA-DR influence, as demonstrated by discrepancies in
VB JB usage between identical twins discordant for RA
and by the contraction of the repertoire in RA patients.
The shape imposed on the repertoire by HLA-DR probably
constitutes a predisposing frame, which is further modified
to obtain the contracted rheumatoid repertoire. The nature
of the factor(s) that determine the final modeling of the
HLA-DR preshaped repertoire is a mystery.
Acknowledgements
This work was funded by INSERM, ARP, PHRC1997, Societe Française de
Rhumatologie. The author expresses many thanks to Cornelia Weyand and
Hitoshi Kohsaka for helpful discussion.
References
Articles of particular interest have been highlighted as:
• of special interest
•• of outstanding interest
1. Gregersen P, Silver J, Winchester R: The shared epitope hypothe-
sis. An approach to understanding the molecular genetics of sus-
ceptibility to rheumatoid arthritis. Arthritis Rheum 1987, 30:1205–
1213.
2. Kohsaka H, Carson DA, Miyasaka N: Formation of peripheral 
•• immunoreceptor repertoire for antigens. Arthritis Rheum 1998, 41:
1911–1918.
A very clear overview of the B and T cell repertoire in normals and RA
patients.
3. Gulwani-Akolkar B, Posnett D, Janson C, et al: T cell receptor V
segment frequencies in peripheral blood T cells correlate with
human leucocyte antigen type. J Exp Med 1991, 174:1139–1146.
4. Kohsaka H, Taniguchi A, Chen P, Ollier WR, Carson DA: The
expressed T cell receptor V gene repertoire of rheumatoid arthri-
tis monozygotic twins: rapid analysis by anchored polymerase
chain reaction and enzyme linked immunosorbent assay. Eur J
Immunol 1993,  23:1895–1901.
5. Paliard X, West S, Lafferty J, et al: Evidence for the effects of a
superantigen in rheumatoid arthritis. Science 1991, 253:325–329.
6. Kohsaka H, Nanki T, Ollier W, Miyasaka N, Carson DA: Influence of
the rheumatoid arthritis associated shared epitope on T cell
receptor repertoire formation. Proc Am Acad Physicians 1996, 108:
323–328.
7. Walser-Kuntz D, Weyand C, Weaver A, O’Fallon W, Goronzy J: Mech-
anisms underlying the formation of the T cell receptor repertoire
in rheumatoid arthritis. Immunity 1995, 2:597–605.
8. Nanki T, Kohsaka H, Mizushima N, Ollier W, Carson DA, Miyasaka N:
Genetic control of T cell receptor BJ gene expression in peripheral
lymphocytes of normal and rheumatoid arthritis monozygotic
twins.  J Clin Invest 1996, 98:1594–1601.9. Mizushima N, Kohsaka H, Nanki T, Ollier W, Carson DA, Miyasaka N:
HLA-dependent T cell receptor repertoire formation and its modi-
fication by rheumatoid arthritis. Clin Exp Immunol 1997, 110:428–
433.
10. Wagner U, Koetz K, Weyand C, Goronzy J: Perturbation of the 
•• T cell repertoire in rheumatoid arthritis. Proc Natl Acad Sci USA
1998, 95:14447–14452.
This article demonstrates contraction of the T cell repertoire of peripheral
blood CD4 T lymphocytes in RA.
11. Weyand C, Goronzy J: T cell responses in rheumatoid arthritis:
systemic abnormalities, local disease. Curr Opin Rheumatol 1999,
11:210–217.
12. Roudier J, Sette A, Lamont A, et al: Tolerance to a self peptide from
the third hypervariable region of the IEb bs chain. Implications for
molecular mimicry models of autoimmune disease. Eur J Immunol
1991, 21:2063–2067.
13. Salvat S, Auger I, Rochelle L, Begovich A, Sette A, Roudier J: Toler-
• ance to a self peptide from the third hypervariable region of HLA 
DRB1*0401. Implications for the association of HLA-DR4 with 
rheumatoid arthritis. J Immunol 1994, 153:5321–5329.
This article demonstrates that the shared epitope on DRB1*0401 is toler-
ated in normal humans.
14. Albani S, Roudier J: From the shared epitope hypothesis to a pep-
• tidic model of rheumatoid arthritis. Clin Biochem 1992, 25:
209–212.
This article proposes that peptides from the third hypervariable regions of
HLA-DR molecules shape the T cell repertoire and are responsible for the
association of the shared epitope with RA.
15. Auger I, Escola J, Gorvel J, Roudier J: HLA-DR4 and HLA-DR10
motifs that carry susceptibility to rheumatoid arthritis bind 70kD
heat shock proteins. Nat Med 1996, 2:306–310.
16. Roudier J, Petersen J, Rhodes G, Luka J, Carson DA: Susceptibility to
rheumatoid arthritis maps to a T cell epitope shared by the HLA-
Dw4 DR beta 1 chain and the Epstein Barr virus glycoprotein
gp110.  Proc Natl Acad Sci USA 1989, 86:5104–5108.
17. Albani S, Tuckwell J, Esparza L, Carson D, Roudier J: The susceptibil-
ity sequence to rheumatoid arthritis is a cross reactive B epitope
shared by the E. coli DnaJ heat shock protein and the HLA-
DRB1*0401 molecule. J Clin Invest 1992, 89:327–331.
18. Albani S, Keystone E, Nelson J, et al: Positive selection in autoim-
munity: abnormal immune responses to a bacterial dnaJ antigenic
determinant in patients with early rheumatoid arthritis. Nat Med
1995, 1:448–452.
19. Bonnin D, Prakken B, Samodal R, La Cava A, Carson DA, Albani S: 
• Ontogeny of synonymous T cell populations with specificity for a 
self MHC epitope mimicked by a bacterial homologue: an antigen 
specific analysis in a non transgenic system. Eur J Immunol 1999, 
29:3826–3836.
An in vitro attempt to demonstrate positive T cell selection by an Ea derived
peptide.
20. Toussirot E, Auger I, Roudier C, et al: HLA-DR polymorphism influ-
ences T cell precursor frequencies to Epstein–Barr virus gp110.
implications for the association of HLA-DR antigens with rheuma-
toid arthritis. Tissue Antigens 1999, 54:146–152.
21. Curtsinger J, Liu Y, Radeke R, et al: Molecular analysis of the
immune response to human cytomegalovirus gB. Low gB specific
T and B cell responses are associated with expression of certain
HLA-DR alleles. J Gen Virol 1994, 75:301–307.
Author’s affiliation: Laboratoire d’Immunorhumatologie, INSERM
EPI9940, Faculté de Médecine, Marseille, France
Correspondence: Jean Roudier, Laboratoire d’Immunorhumatologie,
INSERM EPI9940, Faculté de Médecine, 13005 Marseille, France.
Tel: +33 491 32 44 97; fax: +33 491 83 09 26;
e-mail: jean.roudier@medecine.univ-mrs.fr
Arthritis Research    Vol 2 No 3 Roudier